Thermo Fisher Scientific Inc (TMO) Shares Sold by Martin Investment Management LLC


Stevens Capital Management Lp who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $76.90 billion market cap company. The stock presently has a consensus rating of "Buy" and an average target price of $203.64. About 246,998 shares traded. It has been assigned a low target price of $172 and a high target price of $225. (NYSE:TMO) has risen 15.57% since October 10, 2016 and is uptrending. It has underperformed by 3.17% the S&P500. Thermo Fisher Scientific comprises 3.6% of Martin Investment Management LLC's portfolio, making the stock its 10th largest holding. Therefore 25% are positive. Thermo Fisher Scientific had 45 analyst reports since July 24, 2015 according to SRatingsIntel. (NYSE:TMO) rating on Tuesday, May 3. Mizuho maintained Thermo Fisher Scientific Inc. Axiom Capital maintained the stock with "Buy" rating in Friday, February 5 report. The stock has "Buy" rating by Mizuho on Friday, May 27. (NASDAQ:PTCT) earned "Outperform" rating by Credit Suisse on Monday, November 14. On Monday, October 9 the stock rating was maintained by Leerink Swann with "Outperform". Keefe Bruyette & Woods maintained it with "Outperform" rating and $51 target in Tuesday, January 19 report. As per Tuesday, July 11, the company rating was initiated by Jefferies. These analysts will typically also include ratings and estimates in their reports.

Since May 24, 2017, it had 0 insider purchases, and 3 sales for $4.70 million activity. Another trade for 4,688 shares valued at $805,750 was sold by Shine Daniel P. (NYSE:TMO) were released by: and their article: "Thermo Fisher, Dominant And Growing" published on September 21, 2017 as well as's news article titled: "Thermo Fisher Scientific Inc (TMO) Ex-Dividend Date Scheduled for September 14 ..." with publication date: September 13, 2017. Fifth Third Bankshares owns 53,769 shares for 0.07% of their portfolio. (NYSE:TMO) to report earnings on October, 26.

Investors sentiment decreased to 0.91 in Q2 2017. Its up 0.61, from 1.2 in 2017Q1. It is negative, as 43 investors sold Thermo Fisher Scientific Inc. shares while 415 reduced holdings.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Pointstate L P reported 43,000 shares. Bluestein R H And stated it has 1,552 shares or 0.02% of all its holdings. They expect $2.24 EPS, up 10.34% or $0.21 from last year's $2.03 per share. Veritas Investment Management (Uk) Ltd, a United Kingdom-based fund reported 109,425 shares. Fukoku Mutual Life Insur Co reported 1,900 shares. Sawgrass Asset Limited Liability Corporation stated it has 0.09% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Point72 Asset Mngmt Limited Partnership holds 0.12% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Caledonia Investments Public Limited Company holds 8.35% or 168,917 shares. Peak6 Investments LP holds 13,725 shares. (NYSE:TMO) for 1,643 shares. Proficio Capital Partners LLC now owns 607 shares of the medical research company's stock worth $105,000 after buying an additional 253 shares in the last quarter.

Western Digital Announces 'Breakthrough' In Disk-Drive Storage
MAMR, on the other hand, demonstrates reliability and a cost profile that meets the demands of data centres. The higher heat required for HAMR impacts reliability of the media, head and interface materials.

Over the past five trading sessions shares of Zillow Group, Inc.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at 193.46 on Thursday. (NYSE:TMO) for 761,366 shares. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Thermo Fisher Scientific by 1.8% during the first quarter.

Investors sentiment decreased to 0.94 in 2017 Q2. Its up 0.19, from 1.17 in 2017Q1. 112 funds opened positions while 612 raised stakes. 26,749 were reported by Gateway Inv Advisers Lc. Bollard Group Ltd Com invested in 202 shares or 0% of the stock. Moreover, Vaughan David Investments Il has 1.29% invested in Pfizer Inc. Following the completion of the sale, the director now directly owns 38,757 shares of the company's stock, valued at approximately $6,702,635.58. Royal National Bank Of Canada invested in 65 shares or 0% of the stock. (NASDAQ:PDFS). Td Asset Mngmt holds 41,095 shares or 0% of its portfolio. (NYSE:PFE) for 12,442 shares. 7,355 were reported by Atria Ltd Liability. Great West Life Assurance Can has invested 0% in PDF Solutions, Inc. (NYSE:PFE) for 560,163 shares. Alphaone Investment Services reported 79,300 shares. Ct Mason invested 0.2% of its portfolio in Pfizer Inc. (NYSE:PFE) news were published by: which released: "Going Long Pfizer Inc". The business's revenue for the quarter was up 10.2% on a year-over-year basis. More interesting news about Pfizer Inc. Also, Director C Martin Harris sold 360 shares of the firm's stock in a transaction dated Wednesday, August 30th. (TMO). The consensus rating is 1.5, indicating analysts in general look favorably on the company's future prospects. Therefore 51% are positive. The rating was maintained by Piper Jaffray on Friday, August 14 with "Buy". The rating was maintained by Jefferies with "Hold" on Friday, July 7. That puts the market capitalization at $77.12 bln. BMO Capital Markets has "Buy" rating and $37.0 target. The stock of Citigroup Inc (NYSE:C) has "Hold" rating given on Thursday, August 6 by Vetr. The firm earned "Hold" rating on Thursday, November 5 by Jefferies. The stock decreased 2.63% or $0.15 on October 12, reaching $5.55. As always, the values may need to be adjusted based on the specific stock and market. As per Thursday, September 22, the company rating was initiated by JP Morgan. Piper Jaffray maintained Pfizer Inc. The firm has "Neutral" rating given on Wednesday, November 25 by Suntrust Robinson.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.